Source: Programme & Abstracts. Conference titles: European Muscle Conference (EMC). Unidade: FMRP
Subjects: PROTEÍNAS, ATROFIA MUSCULAR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRA, E. C. et al. Rolipram, a selective phosphodiesterase 4 inhibitor, reduces muscle protein catabolism by inhibiting atrophy/autophagy-related genes expression through cAMP pathway. 2010, Anais.. Pádua: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 01 nov. 2024.APA
Lira, E. C., Parreiras-e-Silva, L. T., Zanon, N. M., Costa Neto, C. M. da, Kettelhut, I. do C., & Navegantes, L. C. C. (2010). Rolipram, a selective phosphodiesterase 4 inhibitor, reduces muscle protein catabolism by inhibiting atrophy/autophagy-related genes expression through cAMP pathway. In Programme & Abstracts. Pádua: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Lira EC, Parreiras-e-Silva LT, Zanon NM, Costa Neto CM da, Kettelhut I do C, Navegantes LCC. Rolipram, a selective phosphodiesterase 4 inhibitor, reduces muscle protein catabolism by inhibiting atrophy/autophagy-related genes expression through cAMP pathway. Programme & Abstracts. 2010 ;[citado 2024 nov. 01 ]Vancouver
Lira EC, Parreiras-e-Silva LT, Zanon NM, Costa Neto CM da, Kettelhut I do C, Navegantes LCC. Rolipram, a selective phosphodiesterase 4 inhibitor, reduces muscle protein catabolism by inhibiting atrophy/autophagy-related genes expression through cAMP pathway. Programme & Abstracts. 2010 ;[citado 2024 nov. 01 ]
